USD 899.0
(0.45%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | 104.71 Million |
Net Income | - | - | - | - | - | 34.17 Million |
Depreciation & Amortization | - | - | - | - | - | 78.8 Million |
Deferred income taxes | - | - | - | - | - | -21.97 Million |
Stock-based compensation | - | - | - | - | - | 5119.00 |
Change in working capital | - | - | - | - | - | 3.13 Million |
Other non-cash items | - | - | - | - | - | 10.57 Million |
Investing Cash Flow | - | - | - | - | - | -32.21 Million |
Investments in PPE | - | - | - | - | - | -36.86 Million |
Acquisitions | - | - | - | - | - | 4.4 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | 250 Thousand |
Other Investing Activities | - | - | - | - | - | 4.4 Million |
Financing Cash Flow | - | - | - | - | - | -62.54 Million |
Debt repayment | - | - | - | - | - | -429.18 Million |
Dividends payments | - | - | - | - | - | -31.7 Million |
Common Stock Repurchased | - | - | - | - | - | -711 Thousand |
Common Stock Issuance | - | - | - | - | - | 191 Thousand |
Other Financing Activities | - | - | - | - | - | 398.86 Million |
Accounts receivables | - | - | - | - | - | -19.07 Million |
Accounts payables | - | - | - | - | - | 33.8 Million |
Inventory | - | - | - | - | - | -3.91 Million |
Other working capital | - | - | - | - | - | -7.68 Million |
Cash at beginning of period | - | - | - | - | - | 43.4 Million |
Cash at end of period | - | - | - | - | - | 54.01 Million |
Capital Expenditure | - | - | - | - | - | -36.86 Million |
Effect of forex changes on cash | - | - | - | - | - | 660 Thousand |
Net cash flow / Change in cash | - | - | - | - | - | 10.61 Million |
Free Cash Flow | - | - | - | - | - | 67.85 Million |
Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | - | 5.27 Million |
Depreciation & Amortization | - | - | - | - | - | 19.22 Million |
Deferred income taxes | - | - | - | - | - | -5.21 Million |
Stock-based compensation | - | - | - | - | - | 134.00 |
Change in working capital | - | - | - | - | - | 25.93 Million |
Other non-cash items | - | - | - | - | - | 803 Thousand |
Investing Cash Flow | - | - | - | - | - | -7.6 Million |
Investments in PPE | - | - | - | - | - | -7.7 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | 94 Thousand |
Financing Cash Flow | - | - | - | - | - | -37.81 Million |
Debt repayment | - | - | - | - | - | -224.01 Million |
Dividends payments | - | - | - | - | - | -7.93 Million |
Common Stock Repurchased | - | - | - | - | - | 194 Million |
Common Stock Issuance | - | - | - | - | - | 117 Thousand |
Other Financing Activities | - | - | - | - | - | 194.01 Million |
Accounts receivables | - | - | - | - | - | -19.87 Million |
Accounts payables | - | - | - | - | - | 4.54 Million |
Inventory | - | - | - | - | - | 29.44 Million |
Other working capital | - | - | - | - | - | 11.82 Million |
Cash at beginning of period | - | - | - | - | - | 51.64 Million |
Cash at end of period | - | - | - | - | - | 52 Million |
Capital Expenditure | - | - | - | - | - | -7.7 Million |
Effect of forex changes on cash | - | - | - | - | - | -239 Thousand |
Net cash flow / Change in cash | - | - | - | - | - | 358 Thousand |
Free Cash Flow | - | - | - | - | - | 38.31 Million |
REBN
EBO
3668
RMD
CTRA
TOM